We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TACO
7101
CALL
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$153K ﹤0.01%
12,600
-7,500
-37% -$96.9K
PLUG icon
7102
Plug Power
PLUG
$3.24B
$152K ﹤0.01%
64,439
-34,879
-35% -$89.4K
ICL icon
7103
ICL Group
ICL
$7.16B
$151K ﹤0.01%
37,363
-10,735
-22% -$44.6K
IRWD icon
7104
CALL
Ironwood Pharmaceuticals
IRWD
$712M
$151K ﹤0.01%
+12,059
New +$158K
TEF
7105
PUT
DELISTED
Telefonica
TEF
$151K ﹤0.01%
19,306
-10,149
-34% -$83.3K
XFLT
7106
XAI Floating Rate & Alternative Income Trust
XFLT
$294M
$151K ﹤0.01%
+3,213
New +$165K
DMK
7107
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$151K ﹤0.01%
490
+274
+127% +$90.1K
ASRT
7108
DELISTED
Assertio
ASRT
$150K ﹤0.01%
311
-5,636
-95% -$2.19M
ADXS
7109
DELISTED
Advaxis Inc
ADXS
$150K ﹤0.01%
3,520
-22,242
-86% -$1.13M
CEL
7110
DELISTED
Cellcom Israel, Ltd.
CEL
$150K ﹤0.01%
+14,684
New +$142K
YMLI
7111
DELISTED
VanEck Vectors High Income Infrastructure MLP ETF
YMLI
$150K ﹤0.01%
+11,175
New +$150K
TNTR
7112
DELISTED
Tintri, Inc. Common Stock
TNTR
$150K ﹤0.01%
+29,436
New +$131K
PRDO icon
7113
CALL
Perdoceo Education
PRDO
$2B
$149K ﹤0.01%
12,300
+1,500
+14% +$17.8K
SA
7114
CALL
Seabridge Gold
SA
$3.61B
$149K ﹤0.01%
13,200
-40,800
-76% -$484K
MDR
7115
CALL
DELISTED
McDermott International
MDR
$149K ﹤0.01%
7,533
-11,134
-60% -$235K
VIIX
7116
DELISTED
VelocityShares VIX Short Term ETN
VIIX
$149K ﹤0.01%
+2,530
New +$176K
INVA icon
7117
PUT
Innoviva
INVA
$1.53B
$148K ﹤0.01%
+10,400
New +$139K
INFN
7118
DELISTED
Infinera Corporation Common Stock
INFN
$148K ﹤0.01%
23,454
-284,912
-92% -$2.17M
ADXS
7119
PUT
DELISTED
Advaxis Inc
ADXS
$148K ﹤0.01%
3,480
-573
-14% -$29K
PCMI
7120
DELISTED
PCM, Inc
PCMI
$148K ﹤0.01%
14,991
+3,244
+28% +$37.3K
APLP
7121
PUT
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
$148K ﹤0.01%
12,400
+800
+7% +$10K
AMKR icon
7122
PUT
Amkor Technology
AMKR
$14.7B
$147K ﹤0.01%
+14,600
New +$156K
ABUS icon
7123
Arbutus Biopharma
ABUS
$924M
$146K ﹤0.01%
+28,816
New +$169K
OSPN icon
7124
PUT
OneSpan
OSPN
$602M
$146K ﹤0.01%
+10,500
New +$139K
SPN
7125
CALL
DELISTED
Superior Energy Services, Inc.
SPN
$146K ﹤0.01%
1,520
-1,020
-40% -$94.7K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.